Zogenix falls after FDA panel rebuffs Zohydro ER

Zogenix Inc. (NASDAQ:ZGNX) fell $1.20 (51%) to $1.16 on Monday after an FDA panel voted 11-2 with one abstention on Friday against approval of Zohydro ER hydrocodone bitartrate to manage moderate to s...